Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$5.4 million.

  • Integra Lifesciences Holdings' Income from Continuing Operations rose 4947.17% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$495.3 million, marking a year-over-year decrease of 746930.01%. This contributed to the annual value of -$6.9 million for FY2024, which is 11025.08% down from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Income from Continuing Operations stood at -$5.4 million for Q3 2025, which was up 4947.17% from -$484.1 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Income from Continuing Operations ranged from a high of $52.9 million in Q4 2022 and a low of -$484.1 million during Q2 2025
  • Moreover, its 5-year median value for Income from Continuing Operations was $19.8 million (2023), whereas its average is -$5.5 million.
  • In the last 5 years, Integra Lifesciences Holdings' Income from Continuing Operations skyrocketed by 960352.3% in 2021 and then crashed by 380318.5% in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Income from Continuing Operations stood at $45.4 million in 2021, then grew by 16.66% to $52.9 million in 2022, then crashed by 62.54% to $19.8 million in 2023, then dropped by 2.01% to $19.4 million in 2024, then tumbled by 127.81% to -$5.4 million in 2025.
  • Its Income from Continuing Operations was -$5.4 million in Q3 2025, compared to -$484.1 million in Q2 2025 and -$25.3 million in Q1 2025.